Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Shareholder Value

Ads

You May Also Like

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation

 ORION CORPORATION                                            PRESS RELEASE                      10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & ...

TESARO Announces Fourth-Quarter 2016 Operating Results

Niraparib NDA under review by FDA; pre-launch preparations for planned commercial launch well underwayExpanded ...